Finance

Lists
Why is ATHE down 6,95%?
Dive Deeper
ATHE:NASDAQ
Alterity Therapeutics Ltd
US$1,54
-6,95%
(-0,12) 1D
20 ພ.ຈ., 14 ໂມງ 33 ນາທີ 22 ວິນາທີ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ATHE...
Open
US$1,59
High
US$1,64
Low
US$1,52
Mkt. cap
27,84 ລ້ານ
Avg. vol.
168,12 ພັນ
Volume
19,65 ພັນ
52-wk high
US$5,89
52-wk low
US$1,52
EPS
US$-0,89
Beta
0,39
Shares outstanding
19,10 ລ້ານ
No. of employees
11
Open
US$1,59
High
US$1,64
Low
US$1,52
Mkt. cap
27,84 ລ້ານ
Avg. vol.
168,12 ພັນ
Volume
19,65 ພັນ
52-wk high
US$5,89
52-wk low
US$1,52
EPS
US$-0,89
Beta
0,39
Shares outstanding
19,10 ລ້ານ
No. of employees
11
News stories
From web sources and news partners
About Alterity Therapeutics Ltd
CEO-
Employees11
Founded1997
Headquartersເມລເບີນ, Victoria, ອອສເຕຣເລຍ
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 3 analysts giving stock ratings to ATHE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ATHE in the last 3 months.
Highest
Current US$1,54
US$16,00 (+938,96%)
Average
US$13,67 (+787,66%)
Lowest
US$10,00 (+549,35%)
Analyst
Recommendation
Action
Price target
Projected
Date
Thomas Flaten
Lake Street
Buy
Maintained
US$10,00
+549,4%
10/05/2026
Adam Vogel
Craig-Hallum
Buy
Reiterated
US$15,00
+874%
10/05/2026
Debanjana Chatterjee
JonesTrading
Buy
Maintained
US$16,00
+939%
08/28/2026
Caroline Palomeque
Ladenburg Thalmann & Co.
Buy
Initiated
US$10,00
+549,4%
06/16/2026
Unknown Analyst
Ladenburg Thalmann & Co.
Buy
Initiated
US$10,00
+549,4%
06/16/2026
Jason McCarthy
Maxim Group
Buy
Reiterated
US$12,00
+679,2%
06/10/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
1,40 ລ້ານ
1,40 ລ້ານ
403,29 ພັນ
403,29 ພັນ
Cost of goods sold
49,43 ພັນ
49,43 ພັນ
81,96 ພັນ
81,96 ພັນ
Cost of revenue
49,43 ພັນ
49,43 ພັນ
81,96 ພັນ
81,96 ພັນ
Research and development expenses
3,92 ລ້ານ
3,92 ລ້ານ
4,89 ລ້ານ
4,89 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,56 ລ້ານ
2,56 ລ້ານ
2,71 ລ້ານ
2,71 ລ້ານ
Operating expense
6,57 ລ້ານ
6,57 ລ້ານ
7,65 ລ້ານ
7,65 ລ້ານ
Total operating expenses
6,62 ລ້ານ
6,62 ລ້ານ
7,73 ລ້ານ
7,73 ລ້ານ
Operating income
-5,22 ລ້ານ
-5,22 ລ້ານ
-7,32 ລ້ານ
-7,32 ລ້ານ
Other non operating income
-
-
-
-
EBT including unusual items
-4,78 ລ້ານ
-4,78 ລ້ານ
-6,87 ລ້ານ
-6,87 ລ້ານ
EBT excluding unusual items
-4,78 ລ້ານ
-4,78 ລ້ານ
-6,87 ລ້ານ
-6,87 ລ້ານ
Income tax expense
30,78 ພັນ
30,78 ພັນ
25,97 ພັນ
25,97 ພັນ
Effective tax rate
-0,64%
-0,64%
-0,38%
-0,38%
Other operating expenses
95,67 ພັນ
95,67 ພັນ
46,26 ພັນ
46,26 ພັນ
Net income
-4,81 ລ້ານ
-4,81 ລ້ານ
-6,89 ລ້ານ
-6,89 ລ້ານ
Net profit margin
-343,00%
-343,00%
-1.709,06%
-1.709,06%
Earnings per share
-
-
-
-
Interest and investment income
454,88 ພັນ
454,88 ພັນ
403,45 ພັນ
403,45 ພັນ
Interest expense
-
-
-
-
Net interest expenses
454,88 ພັນ
454,88 ພັນ
403,45 ພັນ
403,45 ພັນ
Depreciation and amortization charges
-
-
-
-
EBITDA
-5,22 ລ້ານ
-5,22 ລ້ານ
-7,32 ລ້ານ
-7,32 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google